EN
L 52/16
Official Journal of the European Union
20.2.2023
ANNEX III
Information to be included in the official vaccination plan PART 1
1.
Kept animals (a) the description and the results of the assessment performed in accordance with Annex II, including the epidemiological situation and the relevant information used as a basis for the assessment; (b) the main objectives and targets with the chosen vaccination strategy and the official vaccination plan; (c) the detailed geographic description of the vaccination zone in which vaccination is to be carried out and the location of establishments keeping animals to be vaccinated, when available and applicable, including maps; (d) where relevant, the detailed geographic description of the peri-vaccination zone surrounding the vaccination zone, and the location of establishments keeping animals of listed species, when available, including maps; (e) the number of establishments keeping animals of listed species located in the vaccination zone and the number of establishments in which vaccination is to be carried out, if different; (f)
the estimated number of kept animals of listed species to be vaccinated, their categories and, when relevant, their age;
(g) intended final use of vaccinated animals and products; (h) categories of animals exempted from vaccination and reasoning; (i)
the arrangements to administer the vaccine and the system to supervise the administration of the vaccine;
(j)
the envisaged duration of the vaccination, from the start of the vaccination to the end of the surveillance carried out after vaccination;
(k) the summary of the characteristics of the vaccine, including the name of the product(s) and the name of the manufacturer(s), and routes of administration; (l)
indication if the vaccine is used in accordance with Article 110(2) of Regulation (EU) 2019/6;
(m) the details of the reinforced clinical and laboratory surveillance referred to in Article 9, point 1(c) and Article 10, point 2(b); (n) the hygiene and biosecurity rules to be applied; (o) the record keeping system on the vaccination; (p) the restrictions on movements of vaccinated animals and products thereof and other risk-mitigating measures to control the potential spread of disease to be put in place and their duration in addition to those provided for in this Regulation; (q) communication campaign to be put in place to inform operators and the public about the vaccination, including the safety for human consumption of products of animal origin from vaccinated animals of listed species; (r) other matters deemed appropriate to the situation by the competent authority.